Alebund
Financing Round
- Series C
Round Led or Co-led By SymBiosis
Alebund Pharmaceuticals is a clinical-stage biopharmaceutical company developing innovative therapies for kidney diseases and related chronic conditions. Its diversified pipeline targets indications such as chronic kidney disease (CKD), IgA nephropathy, diabetic kidney disease, focal segmental glomerulosclerosis (FSGS), and autosomal dominant polycystic kidney disease (ADPKD).
View Website
Modality
- Small Molecule
Indication
- Circulatory & Metabolic Disease
Development Status
- Phase 3